Compare NTB & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTB | LMAT |
|---|---|---|
| Founded | 1858 | 1983 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2016 | 2006 |
| Metric | NTB | LMAT |
|---|---|---|
| Price | $55.65 | $112.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $53.75 | ★ $105.80 |
| AVG Volume (30 Days) | 145.7K | ★ 207.8K |
| Earning Date | 04-24-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.68% | 0.91% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 2.52 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | $0.88 | $14.21 |
| Revenue Next Year | $4.21 | $8.88 |
| P/E Ratio | ★ $9.64 | $43.70 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $34.86 | $78.01 |
| 52 Week High | $55.84 | $115.33 |
| Indicator | NTB | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 77.09 | 64.28 |
| Support Level | $51.23 | $81.98 |
| Resistance Level | $55.84 | $113.40 |
| Average True Range (ATR) | 0.90 | 3.60 |
| MACD | 0.44 | -0.41 |
| Stochastic Oscillator | 91.33 | 91.10 |
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.